Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study
Journal
-
- Respiratory Research
-
Respiratory Research 15 (1), 2014-07-11
Springer Science and Business Media LLC
- Tweet
Details 詳細情報について
-
- CRID
- 1363670319769622784
-
- ISSN
- 1465993X
-
- Data Source
-
- Crossref